Selling And Administration Expenses تغییر دادن تاریخ
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
ALKERMES USD 167.95M 37.31M 2023-09
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bristol-Myers Squibb USD 2.06B 126M 2023-12
Cara Therapeutics USD 6.72M 790K 2023-09
Corcept Therapeutics USD 47.15M 1.89M 2023-12
Cytokinetics USD 44.11M 4M 2023-12
Eisai JPY 92.79B 6.7B 2023-09
Eli Lilly USD 1.92B 120.7M 2023-12
Incyte USD 293.86M 25.97M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
J&J USD 5.81B 410M 2023-12
Marinus Pharmaceuticals USD 14.87M 854K 2023-09
Moderna USD 470M 28M 2023-12
Neurocrine Biosciences USD 204.2M 17.6M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
PTC Therapeutics USD 76.29M 4.6M 2023-12
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12
Vanda Pharmaceuticals USD 28.4M 7.7M 2023-06
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09



Acadia Pharmaceuticals فروش و مدیریت هزینه - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2024.